臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 53326837 在线人数 : 1048 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"huang j w"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 316-325 / 943 (共95页)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-07-03T03:34:30Z	Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity	Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:29Z	Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists	Su J.-C.; Chen K.-F.; Chen W.-L.; Liu C.-Y.; Huang J.-W.; Tai W.-T.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:13Z	SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model	Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:12Z	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma	Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:49Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:47Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:42Z	Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))	Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-01T03:16:59Z	Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification	Chao C.-T.;Yeh H.-Y.;Tsai Y.-T.;Chuang P.-H.;Yuan T.-H.;Huang J.-W.;Huei-Wen Chen; Chao C.-T.; Yeh H.-Y.; Tsai Y.-T.; Chuang P.-H.; Yuan T.-H.; Huang J.-W.; HUEI-WEN CHEN
臺大學術典藏	2021-07-01T03:16:58Z	Astaxanthin counteracts vascular calcification in vitro through an early up-regulation of SOD2 based on a transcriptomic approach	Chao C.-T.;Yeh H.-Y.;Tsai Y.-T.;Yuan T.-H.;Liao M.-T.;Huang J.-W.;Huei-Wen Chen; Chao C.-T.; Yeh H.-Y.; Tsai Y.-T.; Yuan T.-H.; Liao M.-T.; Huang J.-W.; HUEI-WEN CHEN
臺大學術典藏	2021-06-25T07:22:06Z	Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis	YU-FENG LIN; Huang J.-W.; Wu M.-S.; Chu T.-S.; Lin S.-L.; Chen Y.-M.; Tsai T.-J.; Wu K.-D.

显示项目 316-325 / 943 (共95页)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每页显示[10|25|50]项目